PD06: Prostate Cancer: Detection & Screening I

PD06: Prostate Cancer: Detection & Screening I

Friday, May 15, 2026 1:00 PM to 3:00 PM · 2 hr. (America/New_York)
207A
Poster and Podium Sessions
Oncology: Prostate

Information

Continuing Medical Education
CME

Friday, May 15

PD06-01: Radical prostatectomy without prostate biopsy based on a noninvasive diagnostic strategy: a prospective singlecenter study

Friday, May 15, 2026 1:00 PM to 1:08 PM
207A

PD06-02: A dual-threshold strategy for predicting high-risk prostate cancer in biopsy-free radical prostatectomy cohorts: a retrospective study based on Chinese multicenter clinical data

Friday, May 15, 2026 1:08 PM to 1:16 PM
207A

PD06-03: Safety and Feasibility of Transperineal Prostate Biopsy Without Antibiotic Prophylaxis: A Multicentric Retrospective Study

Friday, May 15, 2026 1:16 PM to 1:24 PM
207A

PD06-04: Detection rate plateau in prostate biopsy: how many cores are enough? A retrospective analysis of two thousand biopsies

Friday, May 15, 2026 1:24 PM to 1:32 PM
207A

PD06-05: Association between heterogeneity of primary prostate cancer on PSMA PET/CT and oncological outcomes in localized cases: a whole-mount pathology-based retrospective study

Friday, May 15, 2026 1:32 PM to 1:40 PM
207A
Yang Luo

PD06-06: A Prospective Study on the Value of CK5/6 Rapid Immunohistochemistry in Rapid Frozen Section Diagnosis of Prostate Targeted Biopsy Specimen

Friday, May 15, 2026 1:40 PM to 1:48 PM
207A

PD06-07: A prospective, paired-cohort, blinded, validation of the Ibex Prostate AI Pathology system compared to expert uro-pathology reporting of prostate biopsies: the Cancer Histology Artificial Intelligence Reliability Study (IP6-CHAIROS)

Friday, May 15, 2026 1:48 PM to 1:56 PM
207A

PD06-08: Comparison of prostate cancer yield per MRI target lesion for LATP versus TRUS prostate biopsy: new insights from the TRANSLATE randomised clinical trial

Friday, May 15, 2026 1:56 PM to 2:04 PM
207A

PD06-09: Diagnostic performance of prostate MRI-based artificial intelligence models in detecting cancer: a systematic review and meta-analysis

Friday, May 15, 2026 2:04 PM to 2:12 PM
207A
Li Jie

PD06-10: Detection Rate of Prostate Cancer Using Prostate-Specific Membrane Antigen/Ultrasound-Fusion Biopsy in Patients with Suspected Recurrence or Inconclusive/Negative Biopsies: A Single-Center Retrospective Study

Friday, May 15, 2026 2:12 PM to 2:20 PM
207A

PD06-11: Predicting Gleason Grade Group at Radical Prostatectomy: A Machine Learning Approach for Prostate Cancer Risk Stratification

Friday, May 15, 2026 2:20 PM to 2:28 PM
207A

PD06-12: Machine Learning-Based Radiomics for Precision Diagnosis in Repeat Prostate Biopsies

Friday, May 15, 2026 2:28 PM to 2:36 PM
207A
Li Jie

PD06-13: Imaging-derived radiomic features as predictive markers of Gleason score assessment in prostate cancer.

Friday, May 15, 2026 2:36 PM to 2:44 PM
207A

PD06-14: The influence of Germline Pathogenic Variants in DNA Repair Genes on a cohort of patients who underwent curativesurgery for Prostate Cancer

Friday, May 15, 2026 2:44 PM to 2:52 PM
207A
Benedetto Calabrese · Humanitas University

PD06-15: Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARPi-Sensitive MMS22L Gene Associated with Increasing Risk of Prostate Cancer

Friday, May 15, 2026 2:52 PM to 3:00 PM
207A

Log in

See all the content and easy-to-use features by logging in or registering!